Literature DB >> 1644107

Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog.

Y Merhi1, J G Latour, A Arsenault, G Rousseau.   

Abstract

Technetium-99m hexakis-2-methoxyisobutyl isonitrile (99mTc-MIBI) distribution is flow-dependent, permitting the imaging of coronary perfusion defects. However, the behaviour of this tracer in viable and necrotic tissues within the ischaemic area at risk is still being debated. In a clinically relevant canine model, dogs were submitted either to a 24-h permanent occlusion (group 1) of the left descending coronary artery (LAD) or to a 90-min LAD occlusion followed by 22.5 h reperfusion (group 2). 99mTc-MIBI and radiolabelled microspheres were injected 3 h before sacrifice. After delimiting the area at risk and the infarct by Evans blue perfusion and triphenyltetrazolium chloride staining, heart slices were imaged by scintigraphy and tissue radioactivity measured in a gamma-counter. In the necrotic area of both groups, the 99mTc-MIBI distribution was proportional to the myocardial blood flow, approximating a 1:1 ratio (identity line slope 1, intercept 0) with highly significant correlation coefficients (group 1 r = 0.87, group 2 r = 0.86), whereas in the viable-ischaemic area of both groups, the data points are widespread above and below the identity line, indicating both over- and underestimations of blood flow in these tissue areas. These results were more pronounced following reperfusion as compared with permanent occlusion. Multiple linear regression analysis confirms differences (P less than 0.001) in 99mTc-MIBI distributions between the viable-ischaemic and the necrotic zones. Delineation of the ischaemic area at risk was possible only with permanent occlusion. A hypoperfused area was observed after reperfusion but differs from the anatomical infarcted area.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644107     DOI: 10.1007/bf00185856

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  23 in total

1.  Spacial and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium.

Authors:  M de Lorgeril; G Rousseau; A Basmadjian; G St-Jean; D C Tran; J G Latour
Journal:  Am J Cardiovasc Pathol       Date:  1990

2.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.

Authors:  J K Kahn; I McGhie; M S Akers; M N Sills; T L Faber; P V Kulkarni; J T Willerson; J R Corbett
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

3.  Myocardial kinetics of 99Tcm hexakis-(2-methoxy-isobutyl-isonitrile) (HMIBI) in patients with coronary heart disease: a comparative study versus 201Tl with SPECT.

Authors:  H Stirner; U Buell; E Kleinhans; R Bares; W Grosse
Journal:  Nucl Med Commun       Date:  1988-01       Impact factor: 1.690

4.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?

Authors:  R S Beanlands; F Dawood; W H Wen; P R McLaughlin; J Butany; G D'Amati; P P Liu
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction.

Authors:  P M De Coster; W Wijns; F Cauwe; A Robert; C Beckers; J A Melin
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

6.  Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.

Authors:  S A Mousa; J M Cooney; S J Williams
Journal:  Am Heart J       Date:  1990-04       Impact factor: 4.749

7.  Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult.

Authors:  R C Canby; S Silber; G M Pohost
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

8.  Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion.

Authors:  P Chatelain; J G Latour; D Tran; M de Lorgeril; G Dupras; M Bourassa
Journal:  Circulation       Date:  1987-05       Impact factor: 29.690

9.  Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium.

Authors:  J A Leppo; D J Meerdink
Journal:  Circ Res       Date:  1989-09       Impact factor: 17.367

10.  Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs.

Authors:  Q S Li; T L Frank; D Franceschi; H N Wagner; L C Becker
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

View more
  5 in total

1.  Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.

Authors:  Z Liu; G Johnson; D Beju; R D Okada
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

2.  Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration.

Authors:  A Peix; A López; F Ponce; J Morales; A R de la Vega; C S Chesa; A M Maltas; D García-Barreto
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

3.  99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.

Authors:  Zhonglin Liu; David R Okada; Gerald Johnson; Sonia D Hocherman; Delia Beju; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

4.  Time course of technetium-99m sestamibi myocardial distribution in dogs with a permanent or transient coronary occlusion.

Authors:  Y Merhi; A Arsenault; J G Latour
Journal:  Eur J Nucl Med       Date:  1994-06

5.  Technetium-99m sestamibi kinetics in reperfused canine myocardium.

Authors:  R D Okada; D K Glover; K N Nguyen; G Johnson
Journal:  Eur J Nucl Med       Date:  1995-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.